Anavex Life Sciences (AVXL) Reports Q1 Loss of $0.12/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. LBRX
2. MRK
3. TRAX
4. LMT
5. FATE
6. KTOS
7. FFAI
8. IRIX
9. BRO
10. AON

Go back to Anavex Life Sciences (AVXL) Reports Q1 Loss of $0.12/Share

Anavex Reports Fiscal First Quarter 2016 Financial Results

February 8, 2016 7:00 AM EST

NEW YORK, Feb. 08, 2016 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (Anavex or the Company) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative diseases including Alzheimers disease, other central nervous system (CNS) diseases, pain and various types of cancer, today reported financial results for the three months ended December 31, 2015.

Financial Highlights:

Anavex had cash and cash equivalents of approximately $13.8 million as of December 31, 2015, compared to approximately $15.3 million as at September 30, 2015.Anavex used approximately $1.5 million in net cash during the first three... More

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Ongoing Investigation of Anavex Life Sciences Corp. and Urges Investors with Losses in Excess of $250,000 to Contact the Firm

February 5, 2016 7:01 PM EST

LOS ANGELES--(BUSINESS WIRE)-- Lundin Law PC announces it is investigating claims against Anavex Life Sciences Corp. (Anavex or the Company) (Nasdaq: AVXL) concerning... More